Issue 2
-
Plenary program kicks with a session dedicated to the science of precancer
Catriona H. M. Jamieson, MD, PhD, previews the Precancer Discover Science plenary, which examined new perspectives on cancer prevention, an integral part of the AACR’s research and health policy efforts.
-
Meeting officially launches Sunday morning with Opening Ceremony, followed by Opening Plenary Session
The Opening Plenary Session reflects the meeting’s theme by showcasing several examples of how researchers are decoding the complexities of cancer, said Program Committee Chair Marcia R. Cruz-Correa, MD, PhD.
-
Schedule highlights from the Program Chair: Saturday, April 9
Annual Meeting Program Committee Chair Marcia R. Cruz-Correa, MD, PhD, shares a few highlights from Saturday’s schedule to help plan your day.
-
Clinical Trials Plenary Sessions will showcase clinical applications of novel therapies
Julie R. Brahmer, MD, MSc, and Timothy A. Yap, MD, PhD, preview the Annual Meeting’s four Clinical Trials Plenary Sessions, which will include important studies looking at cellular therapies, novel immunotherapeutics, and molecularly targeted therapeutics.
-
Pezcoller Award lecturer will recount decades of milestones in the development of immunotherapy
Steven A. Rosenberg, MD, PhD, FAACR, is being recognized for pioneering the development of effective immunotherapies and gene therapies for patients with advanced cancers, among other significant research contributions.
-
AACR honors elite group with scientific achievement awards and lectureships
The AACR honored dozens of cancer researchers, physician-scientists, advocates, and policymakers for their achievements during the Annual Meeting.